In Takeda Pharma v. John J. Doll (08-1131), the US Court of Appeals for the Federal Circuit looked at an earlier District Court decision holding that later developments in the art may inform the “patentably distinct” determination for double patenting. The Federal Circuit agreed but only to the extent that the subsequent developments predate the […]